Track 16: Diabetes Gene Therapy
New approaches to the treatment and cure of type 1 diabetes may be developed as a result of recent advances in molecular and cell biology. In instance, the restoration of insulin secretion through gene or cell-replacement treatment can currently be predicted. Over 180 million individuals worldwide are affected with diabetes mellitus, which is on the rise. The majority of cases of diabetes are type 2, and by 2030, the incidence is anticipated to have more than quadrupled due to the ageing population expansion and sharp rise in obesity prevalence.
Related Conference of Track 16: Diabetes Gene Therapy
November 17-18, 2025
18th International Conference on Human Genomics and Genomic Medicine
Paris, France
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Track 16: Diabetes Gene Therapy Conference Speakers
Recommended Sessions
- Track 10: Cellular Therapies
- Track 11: Advanced Gene Therapeutics
- Track 12: CAR T-cell therapy
- Track 13: Cancer Therapies
- Track 14: Nano-Therapy
- Track 15: Human Gene Therapy
- Track 16: Diabetes Gene Therapy
- Track 17: Molecular Epigenetics
- Track 18: Genetic Vaccines
- Track 19: Clinical Trials and Research in Cell and Gene Therapies
- Track 1: Cell Science and Stem Cell Research
- Track 20: Skin cell therapy
- Track 21: HIV gene therapy
- Track 22: Cell Therapy in Pulmonology
- Track 2: Stem Cell Therapies
- Track 3: Cell Culture and Bioprocessing
- Track 4: Viral gene therapy
- Track 5: Stem Cell in Drug Development
- Track 6: Nanotechnology in Stem Cell
- Track 7: Stem Cell in Cardiovascular Disease
- Track 8: Novel Stem Cell Therapy
- Track 9: Stem cell engineering
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)